Issue Date | Title | Author(s) |
2021-10 | Nanotechnology-based therapeutic formulations in the battle against animal coronaviruses: an update | Krishnan, S; Thirunavukarasu, A; Jha, NK; Gahtori, R; Roy, AS; Dholpuria, S; Kesari, KK; Singh, SK; Dua, K; Gupta, PK |
- | Drug delivery advances in mitigating inflammation via matrix metalloproteinases in respiratory diseases | Mehta, M; Paudel, KR; Panth, N; Xenaki, D; Macloughlin, R; Oliver, BG; Lobenberg, R; Hansbro, PM; Chellappan, DK; Dua, K |
2023-05-17 | Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling. | Bhat, AA; Gilhotra, R; Singh, Y; Sharma, S; Jesus Andreoli Pinto, TD; Ferraz, HG; Singh, SK; Dua, K; Gupta, G |
2022-02-03 | Treating primary lymphoma of the brain in AIDS patients via multifunctional oral nanoparticulate systems. | Jha, SK; Imran, M; Paudel, KR; Mohammed, Y; Hansbro, P; Dua, K |
- | Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases | Chan, Y; MacLoughlin, R; Zacconi, FC; Tambuwala, MM; Pabari, RM; Singh, SK; Jesus Andreoli Pinto, TD; Gupta, G; Chellappan, DK; Dua, K |
2022-07-12 | Special focus issue on targeted drug delivery for inflammatory lung diseases. | Dua, K; Lobenberg, R; Chellappan, DK |
- | Mucoadhesive particles: an emerging toolkit for advanced respiratory drug delivery | Prasher, P; Sharma, M; Singh, SK; Gulati, M; Patravale, V; Oliver, BG; Dua, K |
2023-03-28 | Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases. | Maurya, S; Srivastava, R; Arfin, S; Hawthorne, S; Jha, NK; Agrawal, K; Raj, S; Rathi, B; Kumar, A; Raj, R; Agrawal, S; Paiva-Santos, AC; Malik, AA; Dua, K; Rana, R; Ojha, S; Jha, SK; Sharma, A; Kumar, D; El-Zahaby, SA; Nagar, A |